Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Dec 15, 2024; 16(12): 4614-4624
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4614
Table 1 Clinicopathological characteristics of 33 patients
Variables
n (%) or median (range)
Age (years)61.0 (28.0-75.0)
Gender
Male16 (48.5)
Female17 (51.5)
Diameter of lesion (cm)2.0 (1.0-3.0)
Distance from the anal verge (cm)3.0 (1.0-10.0)
cT baseline
10 (0.0)
29 (27.3)
319 (57.6)
45 (15.2)
cN baseline
Negative8 (24.2)
Positive25 (75.8)
cM baseline
M031 (93.9)
M12 (6.1)
ycT
021 (63.6)
15 (15.2)
26 (18.2)
31 (3.0)
40 (0.0)
ypT
018 (54.5)
16 (18.2)
27 (21.2)
32 (6.1)
40 (0.0)
Differentiation
G13 (9.1)
G229 (87.9)
G31(3.0)
Baseline CEA
Normal32 (97.0)
Abnormal1 (3.0)
Interval between NCRT and surgery (week)25.4 (8.7-164.4)
Chemotherapy
Cap13 (39.4)
CapeOx20 (60.6)
Surgical duration (minute)57.0 (20.0-137.0)
Blood loss (mL)10.0 (5.0-50.0)
Postoperative hospital stay (days)4.0 (1.0-11.0)
Complication
No complication26 (78.8)
With complication7 (21.2)
CD grade
Grade I1 (3)
Grade II6 (18.2)
Grade III-IV0 (0.0)
Recurrence
No31 (93.9)
Yes2 (6.1)
Metastasis (cM0, n = 31)
No28 (90.3)
Yes3 (9.7)
Follow-up time (month)42.0 (4.0-93.5)